Evidence map›Paper›PMID 34311586›Full record

ArticlemBio2021

D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.

Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Sheng-Han Wang, Han-Chieh Kao, Ya-Min Tsai, Hurng-Yi Wang, Chi-Ling Hsieh, You-Yu Lin, Pei-Jer Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Structural evolution of Delta lineage of SARS-CoV-2.International journal of biological macromolecules · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ya-Wen Cheng *Department of Microbiology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Tai-Ling Chao *Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Chiao-Ling LiDepartment of Microbiology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Sheng-Han WangHepatitis Research Center, National Taiwan Universitygrid.19188.39 Hospital, Taipei, Taiwan.
Han-Chieh KaoDepartment of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Ya-Min TsaiDepartment of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Hurng-Yi WangGraduate Institute of Clinical Medicine, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Chi-Ling HsiehDepartment of Microbiology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
You-Yu LinGraduate Institute of Clinical Medicine, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Pei-Jer ChenGraduate Institute of Clinical Medicine, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Sui-Yuan ChangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
Shiou-Hwei YehDepartment of Microbiology, National Taiwan Universitygrid.19188.39 College of Medicine, Taipei, Taiwan.
National Taiwan University · TWNational Taiwan University Hospital · TW

Funding

Ministry of Education (MOE), Higher Education Sprout Project, Taiwan Center of Precision Medicine, The Featured Areas Research Center ProgramMinistry of Science and Technology, Taiwan (MOST) MOST109-2327-B-002-009Ministry of Science and Technology, Taiwan (MOST) MOST109-2634-F-002-043Ministry of Science and Technology, Taiwan (MOST) MOST109-3114-Y-001-001
6 · The paper itself

Abstract

Since the D614G substitution in the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged, the variant strain has undergone a rapid expansion to become the most abundant strain worldwide. Therefore, this substitution may provide an advantage for viral spreading. To explore the mechanism, we analyzed 18 viral isolates containing S proteins with either G614 or D614 (S-G614 and S-D614, respectively). The plaque assay showed a significantly higher virus titer in S-G614 than in S-D614 isolates. We further found increased cleavage of the S protein at the furin substrate site, a key event that promotes syncytium formation, in S-G614 isolates. The enhancement of the D614G substitution in the cleavage of the S protein and in syncytium formation has been validated in cells expressing S protein. The effect on the syncytium was abolished by furin inhibitor treatment and mutation of the furin cleavage site, suggesting its dependence on cleavage by furin. Our study pointed to the impact of the D614G substitution on syncytium formation through enhanced furin-mediated S cleavage, which might increase the transmissibility and infectivity of SARS-CoV-2 strains containing S-G614.

Indexed as

Amino Acid SubstitutionAnimalsCell LineChlorocebus aethiopsCOVID-19FurinGenetic FitnessGenome, ViralGiant CellsHEK293 CellsHumansSARS-CoV-2Spike Glycoprotein, CoronavirusVero CellsViral LoadVirus ReplicationFurinFURIN protein, humanSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2furinSARS-CoV-2spikesyncytium

Identifiers

PMID34311586
PMCPMC8406174
OpenAlexW3183354410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.